• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板衍生生长因子-C(PDGF-C)被丝氨酸蛋白酶激活:对乳腺癌进展的影响。

Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.

机构信息

Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State School of Medicine, Detroit, MI 48201, USA.

出版信息

Biochem J. 2012 Feb 1;441(3):909-18. doi: 10.1042/BJ20111020.

DOI:10.1042/BJ20111020
PMID:22035541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3342761/
Abstract

The PDGF (platelet-derived growth factor) family members are potent mitogens for cells of mesenchymal origin and serve as important regulators of cell migration, survival, apoptosis and transformation. Tumour-derived PDGF ligands are thought to function in both autocrine and paracrine manners, activating receptors on tumour and surrounding stromal cells. PDGF-C and -D are secreted as latent dimers, unlike PDGF-A and -B. Cleavage of the CUB domain from the PDGF-C and -D dimers is required for their biological activity. At present, little is known about the proteolytic processing of PDGF-C, the rate-limiting step in the regulation of PDGF-C activity. In the present study we show that the breast carcinoma cell line MCF7, engineered to overexpress PDGF-C, produces proteases capable of cleaving PDGF-C to its active form. Increased PDGF-C expression enhances cell proliferation, anchorage-independent cell growth and tumour cell motility by autocrine signalling. In addition, MCF7-produced PDGF-C induces fibroblast cell migration in a paracrine manner. Interestingly, PDGF-C enhances tumour cell invasion in the presence of fibroblasts, suggesting a role for tumour-derived PDGF-C in tumour-stromal interactions. In the present study, we identify tPA (tissue plasminogen activator) and matriptase as major proteases for processing of PDGF-C in MCF7 cells. In in vitro studies, we also show that uPA (urokinase-type plasminogen activator) is able to process PDGF-C. Furthermore, by site-directed mutagenesis, we identify the cleavage site for these proteases in PDGF-C. Lastly, we provide evidence suggesting a two-step proteolytic processing of PDGF-C involving creation of a hemidimer, followed by GFD-D (growth factor domain dimer) generation.

摘要

血小板衍生生长因子(PDGF)家族成员是间充质来源细胞的有效有丝分裂原,是细胞迁移、存活、凋亡和转化的重要调节剂。肿瘤衍生的 PDGF 配体被认为以自分泌和旁分泌的方式发挥作用,在肿瘤和周围基质细胞上激活受体。PDGF-C 和 -D 作为潜伏的二聚体分泌,而 PDGF-A 和 -B 则不然。需要从 PDGF-C 和 -D 二聚体中裂解 CUB 结构域,才能发挥其生物学活性。目前,对于 PDGF-C 的蛋白水解加工知之甚少,而 PDGF-C 活性调节的限速步骤。在本研究中,我们表明,过表达 PDGF-C 的乳腺癌细胞系 MCF7 产生能够将 PDGF-C 切割成其活性形式的蛋白酶。增加 PDGF-C 的表达通过自分泌信号增强细胞增殖、锚定非依赖性细胞生长和肿瘤细胞迁移。此外,MCF7 产生的 PDGF-C 以旁分泌方式诱导成纤维细胞迁移。有趣的是,PDGF-C 在存在成纤维细胞的情况下增强肿瘤细胞侵袭,表明肿瘤衍生的 PDGF-C 在肿瘤-基质相互作用中起作用。在本研究中,我们确定 tPA(组织纤溶酶原激活物)和 matriptase 是 MCF7 细胞中 PDGF-C 加工的主要蛋白酶。在体外研究中,我们还表明 uPA(尿激酶型纤溶酶原激活物)能够处理 PDGF-C。此外,通过定点突变,我们确定了这些蛋白酶在 PDGF-C 中的裂解位点。最后,我们提供了证据表明 PDGF-C 的两步蛋白水解加工涉及创建半二聚体,然后是 GFD-D(生长因子域二聚体)生成。

相似文献

1
Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.血小板衍生生长因子-C(PDGF-C)被丝氨酸蛋白酶激活:对乳腺癌进展的影响。
Biochem J. 2012 Feb 1;441(3):909-18. doi: 10.1042/BJ20111020.
2
Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.血小板衍生生长因子D在前列腺癌细胞中被尿激酶型纤溶酶原激活剂激活。
Mol Cell Biol. 2005 Jul;25(14):6279-88. doi: 10.1128/MCB.25.14.6279-6288.2005.
3
The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.尿激酶型纤溶酶原激活物/尿激酶型纤溶酶原激活物受体系统调节血小板衍生生长因子-DD的生物利用度:对肿瘤生长的影响。
Oncogene. 2009 Jan 29;28(4):534-44. doi: 10.1038/onc.2008.410. Epub 2008 Nov 10.
4
Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.组织型纤溶酶原激活剂对于血小板衍生生长因子-C的激活并非必需。
Biochim Biophys Acta. 2014 Feb;1842(2):318-25. doi: 10.1016/j.bbadis.2013.11.013. Epub 2013 Nov 19.
5
A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.人前列腺癌中一种新型的丝氨酸蛋白酶 2/血小板衍生生长因子 D/ß-血小板衍生生长因子受体信号轴。
Cancer Res. 2010 Dec 1;70(23):9631-40. doi: 10.1158/0008-5472.CAN-10-0511. Epub 2010 Nov 23.
6
Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.组织纤溶酶原激活物激活潜伏性血小板衍生生长因子CC的结构要求
J Biol Chem. 2005 Jul 22;280(29):26856-62. doi: 10.1074/jbc.M503388200. Epub 2005 May 23.
7
A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression.血小板衍生生长因子D在前列腺癌进展中的潜在致癌活性。
Cancer Res. 2004 Mar 1;64(5):1722-9. doi: 10.1158/0008-5472.can-03-3047.
8
Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.通过血小板衍生生长因子-D介导的细胞外酸中毒激活和脱落胃蛋白酶。
Am J Physiol Cell Physiol. 2016 Feb 15;310(4):C293-304. doi: 10.1152/ajpcell.00043.2015. Epub 2015 Jul 8.
9
Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.血小板衍生生长因子-D 通过上调 Notch 和 NF-κB 信号通路促进乳腺癌细胞的侵袭性。
Breast Cancer Res Treat. 2011 Feb;126(1):15-25. doi: 10.1007/s10549-010-0883-2. Epub 2010 Apr 9.
10
Dynamic regulation of platelet-derived growth factor D (PDGF-D) activity and extracellular spatial distribution by matriptase-mediated proteolysis.由膜型丝氨酸蛋白酶介导的蛋白水解对血小板衍生生长因子D(PDGF-D)活性及细胞外空间分布的动态调节
J Biol Chem. 2015 Apr 3;290(14):9162-70. doi: 10.1074/jbc.M114.610865. Epub 2015 Feb 12.

引用本文的文献

1
The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy.SUMO家族:在甲状腺癌发病机制与治疗中的作用机制及意义
Biomedicines. 2024 Oct 21;12(10):2408. doi: 10.3390/biomedicines12102408.
2
Age-associated microenvironmental changes highlight the role of PDGF-C in ER breast cancer metastatic relapse.年龄相关的微环境变化突出了 PDGF-C 在 ER 阳性乳腺癌转移复发中的作用。
Nat Cancer. 2023 Apr;4(4):468-484. doi: 10.1038/s43018-023-00525-y. Epub 2023 Mar 13.
3
Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer.伊马替尼通过靶向表观遗传激活的 PDGFC 信号通路增强胰腺癌对吉西他滨的敏感性。
Mol Ther. 2023 Feb 1;31(2):503-516. doi: 10.1016/j.ymthe.2022.11.004. Epub 2022 Nov 15.
4
The production of recombinant platelet-derived growth factor D using the second generation modified vaccinia Ankara viral system.使用第二代改良安卡拉痘苗病毒系统生产重组血小板衍生生长因子 D。
Protein Sci. 2022 Nov;31(11):e4468. doi: 10.1002/pro.4468.
5
Insufficiency of hepatocyte growth factor activator inhibitor-1 confers lymphatic invasion of tongue carcinoma cells.肝细胞生长因子激活物抑制剂-1 不足可导致舌癌细胞发生淋巴管侵袭。
Cancer Sci. 2022 Jun;113(6):2179-2193. doi: 10.1111/cas.15346. Epub 2022 Apr 12.
6
Glycosylation at Asn254 Is Required for the Activation of the PDGF-C Protein.血小板衍生生长因子C(PDGF-C)蛋白的激活需要天冬酰胺254位点的糖基化。
Front Mol Biosci. 2021 May 24;8:665552. doi: 10.3389/fmolb.2021.665552. eCollection 2021.
7
CD146, from a melanoma cell adhesion molecule to a signaling receptor.CD146,从黑色素瘤细胞黏附分子到信号受体。
Signal Transduct Target Ther. 2020 Aug 11;5(1):148. doi: 10.1038/s41392-020-00259-8.
8
An oncogenic activity of PDGF-C and its splice variant in human breast cancer.血小板衍生生长因子C(PDGF-C)及其剪接变体在人类乳腺癌中的致癌活性。
Growth Factors. 2019 Aug;37(3-4):131-145. doi: 10.1080/08977194.2019.1662415. Epub 2019 Sep 23.
9
Cell surface-anchored serine proteases in cancer progression and metastasis.细胞表面锚定的丝氨酸蛋白酶在癌症进展和转移中的作用。
Cancer Metastasis Rev. 2019 Sep;38(3):357-387. doi: 10.1007/s10555-019-09811-7.
10
PHD3 Acts as Tumor Suppressor in Mouse Osteosarcoma and Influences Tumor Vascularization via PDGF-C Signaling.PHD3在小鼠骨肉瘤中作为肿瘤抑制因子,并通过血小板衍生生长因子C(PDGF-C)信号传导影响肿瘤血管生成。
Cancers (Basel). 2018 Dec 6;10(12):496. doi: 10.3390/cancers10120496.

本文引用的文献

1
Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.血小板衍生生长因子-CC的旁分泌信号传导通过募集癌症相关成纤维细胞促进肿瘤生长。
Cancer Res. 2009 Jan 1;69(1):369-78. doi: 10.1158/0008-5472.CAN-08-2724.
2
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.血小板衍生生长因子C(PDGF-C)介导了与抗血管内皮生长因子(VEGF)治疗难治性肿瘤相关的成纤维细胞的血管生成和致瘤特性。
Cancer Cell. 2009 Jan 6;15(1):21-34. doi: 10.1016/j.ccr.2008.12.004.
3
Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.纤溶酶是负责处理增殖性玻璃体视网膜病变患者玻璃体中血小板衍生生长因子-C的主要蛋白酶。
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):42-8. doi: 10.1167/iovs.07-0776.
4
Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.尿激酶型纤溶酶原激活剂的去甲基化相关激活参与前列腺癌进展。
Cancer Res. 2007 Feb 1;67(3):930-9. doi: 10.1158/0008-5472.CAN-06-2892.
5
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.非小细胞肺癌中尿激酶型纤溶酶原激活物和1型纤溶酶原激活物抑制剂:与预后和血管生成的关系
Lung Cancer. 2007 Apr;56(1):43-50. doi: 10.1016/j.lungcan.2006.11.018. Epub 2007 Jan 17.
6
Streptokinase--the drug of choice for thrombolytic therapy.链激酶——溶栓治疗的首选药物。
J Thromb Thrombolysis. 2007 Feb;23(1):9-23. doi: 10.1007/s11239-006-9011-x.
7
Autocrine PDGFR signaling promotes mammary cancer metastasis.自分泌血小板衍生生长因子受体信号传导促进乳腺癌转移。
J Clin Invest. 2006 Jun;116(6):1561-70. doi: 10.1172/JCI24652.
8
Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples.通过表达谱分析鉴定人胰腺腺癌生物标志物并在内镜超声引导下细针穿刺样本中进行基因表达分析验证
World J Gastroenterol. 2006 Jun 7;12(21):3344-51. doi: 10.3748/wjg.v12.i21.3344.
9
Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis.通过酶促基因捕获对matriptase蛋白表达的描绘表明其在屏障功能、毛发形成和鳞状细胞癌发生中具有不同作用。
Am J Pathol. 2006 May;168(5):1513-25. doi: 10.2353/ajpath.2006.051071.
10
Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I.在暴露于胰岛素样生长因子-I的转移性乳腺癌细胞中,组织型纤溶酶原激活剂上调。
Clin Breast Cancer. 2005 Oct;6(4):340-8. doi: 10.3816/CBC.2005.n.038.